🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We are looking for a new study nurse. Interested? Find out more details following this link medizin.uni-tuebingen.de/de/karriere/jo…

Great Nature Communications paper introducing a new streamlined platform for both DDA and DIA data analysis integrates deep learning-based solutions of spectral library search, #database search, and de novo sequencing. nature.com/articles/s4146…

It was a great pleasure for me to present our immunopeptiomics research QBiC | @[email protected]

An oncogenic fusion protein as target for novel #immunotherapies of cancer. We are so excited to share our study, which identified the oncogenic fusion protein DNAJB1-PRKACA as source of #neoantigens for peptide-based immunotherapy in #FLHCC! nature.com/articles/s4146…

So excited that our paper is finally out! #immunopeptidomics #neoantigen

Only 10 days to deadline for HIPP leadership election. Don't forget to submit your nomination!

Looking forward to a great conference! Visualizing and Targeting Cancer Stress

Congratulations Hans-Georg 🍾 Great evening Cancer Immunotherapy #cimt2023

We are #hiring! Did you just finish your #PhD or do you consider a new #PostDoc fellowship? Check out our open positions with focus on #immunopeptidomics and #tcells: jobs.medizin.uni-tuebingen.de/Job/3087/Resea… jobs.medizin.uni-tuebingen.de/Job/3088/Resea…

Our new manuscript is now online Frontiers - Immunology that shows how different immunoprecipitation methods impact the peptide repertoire of immunopeptidomic analysis and therefore the identification of potential #TumorAssociatedAntigens! Check it out: frontiersin.org/articles/10.33…

We are very excited to share the results of the phase I/II clinical trial published in Nature Communications showing that our peptide-based #Tcell activator CoVac-1 elicit potent T-cell responses against SARS-CoV-2 in highly immunocompromised cancer patients: nature.com/articles/s4146…

A great honour to see our paper describing our Phase I/II #clinicaltrial of a peptide-based #COVID19 T-cell activator in #patients with B-cell deficiency highlighted by the editors at Nature Communications. nature.com/collections/je…

We are very excited to see our #research on #HLA-presented #antigens on leukemic stem cells in #AML published in Blood Cancer Discovery: aacrjournals.org/bloodcancerdis…

We identified and functionally validated leukemic stem cell-associated #HLA-presented #antigens that might pave the way to the development of leukemic stem cell-directed #Tcell-based immunotherapeutic approaches for #patients with #AML. Great work of our team member Annika Nel!

Annika Nel A great honor to see our paper on #HLA-presented #antigens on leukemic stem cells highlighted by Jerome Ritz in an associated commentary Blood Cancer Discovery: aacrjournals.org/bloodcancerdis…

Annika Nel Blood Cancer Discovery We would like to thank our collaborators and supporters Visualizing and Targeting Cancer Stress Leukämie-Stiftung Uniklinikum Tübingen Universität Tübingen Universität Freiburg @Medizin_TUD Universität Würzburg #UniWürzburg Stanford Medicine!

So happy to see our research finally puplished Blood Cancer Discovery

Immune Surveillance of #AcuteMyeloidLeukemia Is Mediated by HLA-Presented Antigens on Leukemia Progenitor Cells, by Annika Nel, Peptide-based Immunotherapy et al. bit.ly/46Koyn0 Universität Tübingen Uniklinikum Tübingen Visualizing and Targeting Cancer Stress #Leusm #Immunopeptidomics

It's a wrap! Our Strategy #Retreat and Scientific Advisory Board #Meeting 2023 are in the books! Great discussions, fruitful presentations and constructive feedback in the heart of the #BlackForest! Setting the pace for the prolongation proposal. #CancerResearch #research

From the latest issue— Immune Surveillance of #AcuteMyeloidLeukemia Is Mediated by HLA-Presented Antigens on #Leukemia Progenitor Cells, by Annika Nel, Peptide-based Immunotherapy et al. bit.ly/3uqhptG Universität Tübingen Uniklinikum Tübingen Visualizing and Targeting Cancer Stress #Leusm #Immunopeptidomics #OpenAccess